ALBERTI, Saverio
 Distribuzione geografica
Continente #
EU - Europa 2.053
NA - Nord America 1.875
AS - Asia 774
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.704
Nazione #
US - Stati Uniti d'America 1.848
IE - Irlanda 1.062
CN - Cina 572
SE - Svezia 546
IT - Italia 249
SG - Singapore 129
PL - Polonia 104
IN - India 39
CA - Canada 26
FR - Francia 24
GB - Regno Unito 22
VN - Vietnam 19
BE - Belgio 14
AT - Austria 11
SA - Arabia Saudita 10
ES - Italia 8
DE - Germania 5
FI - Finlandia 5
IR - Iran 3
CH - Svizzera 2
EU - Europa 2
AE - Emirati Arabi Uniti 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
Totale 4.704
Città #
Dublin 1.062
Nyköping 482
Beijing 391
Chandler 353
Princeton 196
Medford 181
Jacksonville 168
Des Moines 147
Warsaw 104
Messina 83
Singapore 72
Ann Arbor 61
Dearborn 42
Wilmington 39
Ashburn 35
Jinan 28
Hyderabad 23
Ottawa 23
Boardman 21
Milan 20
Dong Ket 19
Shenyang 19
Houston 18
Nanjing 17
Zhengzhou 14
Brussels 13
Rome 12
Taizhou 12
Haikou 11
Pune 11
Vienna 11
At Tuwal 10
Naples 10
Tianjin 10
Chieti 9
Lanzhou 9
Ningbo 9
Redwood City 9
Guangzhou 8
San Mateo 8
Hangzhou 7
Hebei 7
Norwalk 7
Falls Church 6
Nanchang 6
Padova 6
Madrid 5
Novara 5
Woodbridge 5
Chions 4
Grassobbio 4
Jiaxing 4
Palermo 4
Seattle 4
Augusta 3
Bologna 3
Castellana Grotte 3
Changsha 3
Fairfield 3
Granada 3
Helsinki 3
Lozzo Atestino 3
Toronto 3
Washington 3
Cagliari 2
Casalnuovo di Napoli 2
Fuzhou 2
Leawood 2
Los Angeles 2
Nichelino 2
Oleggio 2
Parma 2
Reggio Calabria 2
Spoltore 2
Venice 2
Ardabil 1
Brooklyn 1
Cambridge 1
Cepagatti 1
Chengdu 1
Chicago 1
Dallas 1
Dubai 1
Elk Grove Village 1
Hanover 1
Hefei 1
Huzhou 1
Kalmthout 1
Lappeenranta 1
London 1
Monterrey 1
Mumbai 1
New York 1
Nicolosi 1
Piazza Armerina 1
Prineville 1
Qingdao 1
Redmond 1
Riga 1
Sabz 1
Totale 3.921
Nome #
Anticorpi Anti-Trop-2 ed usi connessi 91
The 150 most important questions in cancer research and clinical oncology series: questions 15-24 : Edited by Chinese Journal of Cancer 66
AHTH-EpCAM AHTHTEJIO HErO IIPHMEHEHHE Russia 58
Abandoning the Notion of Non-Small Cell Lung Cancer 56
Epigenetic inheritance and the missing heritability 54
ANASTASI Anna Maria, PETRONZELLI Fiorella, DE SANTIS Rita, ALBERTI Saverio 50
Humanized Anti-Trop-2 Monocolonal Antibodies and Uses Thereof 49
USE OF CIRCULATING SERUM TROP-2 AS NEW TUMOR BIOMARKER - USA 48
Oncoxx Biotech srl - start-up innovativa 47
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF 46
ANTI-EPCAM ANTIBODY AND USES THEREOF - Australia 45
Functional inactivation of E-cadherin by Trop-2 drives cancer metastasis 45
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 45
null 44
ANTI-EPCAM ANTIBODY AND USES THEREOF - South Korea 44
null 44
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis 42
Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer 42
ANTI-EPCAM ANTIBODY AND USES THEREOF China and Hong-Kong 40
ANTI-EPCAM ANTIBODY AND USES THEREOF - Europe 40
Functional inactivation of E-cadherin drives EMT-less metastasis 39
E-cadherin inactivation by Trop-2 drives EMT-less metastatic relapse in triple-negative breast cancer 39
ANTI-EPCAM ANTIBODY AND USES THEREOF 38
Use of Trop-2 as a predictive marker of response to anti-tumor therapy based on inhibitors of CD9 and Akt and molecules of the tetraspanin signalling network 37
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF - Japan 37
Humanized anti-Trop-2 monoclonal antibodies and uses thereof - US 37
null 37
Use of circulating serum Trop-2 as new tumor biomarker 36
TROP2 is a major determinant of growth and metastatic spreading of human cancer 36
Use of Serum Circulating Trop-2 as New Tumor Biomarker 35
The missing folding sequence 35
Abstract PD15-04: Trop-2 inactivation of E-cadherin drives triple negative breast cancer relapse 35
Sensori per acidi nucleici 34
ANTITELO ANTI-EPCAM I NJEGOVE PRIMENE Serbia REPUBLIKA Srbija 34
Humanized Anti-Trop-2 monoclonal antibodies and uses thereof - China 34
null 34
Lack of association between BK virus and ependymomas, malignant tumors of pancreatic islets, osteosarcomas and other human tumors 34
Novel domain-targeted anti-Trop-2 monoclonal antibodies to elicit therapeutic synergy against multiple human cancers 34
RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer 33
NUOVE TECNOLOGIE PER ANALISI DI PROTEOMA 33
Oncoxx srl - Start-up innovativa 33
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and-B breast cancer subtypes 33
null 32
Native, sequential protein folding via anchored N and C protein termini 31
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 31
57P Functional inactivation of E-cadherin by Trop-2 drives cancer metastasis 31
Abstract 2851: Trop-2 inactivates E-cadherin for metastatic diffusion in the absence of EMT 31
USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF AKT 30
null 28
Oligonucleotide sequences that inhibit the expression of chimeric mRNA that control the growth of tumor cells and their use in the medical field 28
null 28
Novel anti-Trop-2 monoclonal antibodies with unique binding specificities show therapeutic synergy against most human cancers 28
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Canada 28
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors 28
Transfection and cloning of genes for membrane antigens using the FACS 27
null 27
Trop-2 is a novel PKC-dependent growth-stimulator trans-membrane molecule and a metastasis marker in human cancer 27
TROP2 is a novel, potent stimulator of tumor growth and of metastatic spreading of human cancer 27
Trop molecules as targets for anti-tumor immunotherapy in man 26
null 26
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF - Canada 26
null 26
Trop-2 stimulates the growth of human cancer cells through fusion to Cyclin D1 26
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Europe 26
null 26
Expression of a 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs 25
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 25
null 25
(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells 25
null 25
null 25
Trop-2 is a general cancer growth stimulator through ubiquitous tetraspanin platforms 25
ANTI-EPCAM ANTIBODY AND USES THEREOF Mexico 25
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 25
Regulation of gene expression in choriocarcinoma cell lines 25
Relationship between large granular lymphocytes and NK-1.2+ cells from normal and poly(inosinic:cytidylic acid) (poly(I:C))-treated mice 24
null 24
Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: Evidence for a second class I locus in cattle 24
A seven-gene CpG-island methylation panel predicts breast cancer progression 24
Comment on "Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice" 24
null 24
DNA methylation prevents transfection of genes for specific surface antigens 24
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Australia 24
A phosphoinositide-binding sequence is shared by PH domain target molecules - A model for the binding of PH domains to proteins 24
Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors 23
A unique four-hub protein cluster associates to glioblastoma progression 23
Molecular cloning, reconstruction and expression of the gene encoding the alpha-chain of the bovine CD-8 - Definition of three peptide regions conserved across species 23
Cyclin DI gene contains a cryptic promoter that is functional in human cancer cells 23
A high affinity T cell receptor? 23
Uses of a fusion RNA between CYCLIN D1 and TROP2 in the diagnosis and therapy of tumors 22
Metastatic growth of a murine tumor: evidence of dissemination to the lungs in the absence of subcutaneous growth 22
Comparative global gene expression analysis identifies TROP2 as a major determinant of growth and metastatic spreading of human cancer 22
Molecular Epidemiology of Breast Cancer 22
Abstract 340: The Hu2G10 tumor-selective anti-Trop-2 monoclonal antibody targets the cleaved-activated Trop-2 and shows therapeutic efficacy against multiple human cancers 21
null 21
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients 21
null 21
null 21
Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells 21
Human height genes and cancer 21
Totale 3.233
Categoria #
all - tutte 27.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020600 8 4 7 19 14 46 12 32 34 121 289 14
2020/2021656 12 10 121 12 262 20 37 44 48 30 24 36
2021/2022796 3 19 1 28 13 8 33 51 31 10 174 425
2022/20232.159 236 143 127 94 77 194 36 91 1.085 10 44 22
2023/2024580 22 58 117 25 49 37 9 88 7 37 8 123
2024/202542 42 0 0 0 0 0 0 0 0 0 0 0
Totale 5.053